This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Academic Highlights

The Role of Norepinephrine in the Treatment of Depression


Published: September 30, 1999

This CME activity is expired. For more CME activities, visit
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Article Abstract

Despite recent strides in treatment, depression remains a common, costly, and often deadly disease, Dr. Charles B. Nemeroff stated. More than 1.2 million persons are diagnosed with an affective disorder in the United States each year, an incidence of approximately 5% to 10%, and depression is more prevalent than arthritis, diabetes, or heart disease. Depression is also a costly disease: in 1990 it was estimated that in the United States alone the cost of depression approached $44 billion, including direct costs for medication, physician services, etc., as well as indirect costs such as increased morbidity, excessive absenteeism, and reduced productivity. Depression also has a high mortality: up to 15% of severely depressed patients will ultimately commit suicide.

Volume: 60

Quick Links:

Continue Reading…

Subscribe to read the entire article


Buy this Article as a PDF